BRTX CIK: 1505497

BioRestorative Therapies, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
0.15
FY24:
0.37
FY25:
0.34
(positive)
Change from FY21 to FY25
millions USD
FY21:
−26.3
FY22:
−19.0
FY23:
−15.2
FY24:
−11.6
FY25:
−15.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−26.2
FY22:
–
FY23:
−15.0
FY24:
−13.2
FY25:
−16.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−44.3
FY22:
–
FY23:
−10.4
FY24:
−8.98
FY25:
−14.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−44.3
FY22:
−13.2
FY23:
−10.4
FY24:
−8.98
FY25:
−14.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data